Document Detail

Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial.
MedLine Citation:
PMID:  15848684     Owner:  NLM     Status:  MEDLINE    
There is no controlled clinical trial on the treatment of de novo arterial hypertension after liver transplantation (LT) a common complication using calcineurin inhibitors (CNI) for immunosuppressive therapy. The aim of this study was to compare the efficacy and safety of nifedipine, a calcium channel blocker, and carvedilol, an alpha1- and beta-blocker. The study included 50 patients who developed arterial hypertension after LT. The data on the first 30 patients who have completed 12-month follow-up are reported herein. Eighteen patients received nifedipine, and 12 patients received carvedilol. Patients were evaluated monthly at the outpatient clinic for 1 year. If patients developed severe adverse effects to nifedipine, they were switched to carvedilol and vice versa (therapy failure). The two groups were similar for clinical features, indications for LT, immunosuppressive therapy, and baseline blood pressures. A failure of treatment was observed in 9 of 18 patients treated with nifedipine (50.0%) and one of 12 patients treated with carvedilol (8%, P < .025). Nifedipine was effective in 4 of 18 patients, carvedilol, in 4 of 12 patients (22.21% vs 33.3%, P = NS). Two of the nine nonresponders to nifedipine responded to carvedilol. The efficacy of monotherapy was observed in 11 of 40 randomized patients (27.5%). Carvedilol monotherapy is as effective as nifedipine but far better tolerated.
A Galioto; P Angeli; S Guarda; P Burra; G Zanus; S Fasolato; S Fagiuoli; A Sticca; A Semplicini; M Sartori; A Carraro; P Boccagni; U Cillo; A Gatta
Related Documents :
14620924 - Current status of lipid management of hypertensive patients.
4025924 - Pisa--a new noninvasive method for early detection and quantification of ischemia in hy...
9707624 - A genetic defect resulting in mild low-renin hypertension.
97124 - Hemostasis in schistosomiasis mansoni.
17096864 - Bench-to-bedside review: thrombocytopenia-associated multiple organ failure--a newly ap...
12017684 - Diabetic nephropathy.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Transplantation proceedings     Volume:  37     ISSN:  0041-1345     ISO Abbreviation:  Transplant. Proc.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-04-25     Completed Date:  2005-09-26     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1245-7     Citation Subset:  IM    
Department of Clinical and Experimental Medicine, University of Padua, Padova, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure
Carbazoles / therapeutic use*
Heart Rate
Hypertension / drug therapy*
Liver Transplantation*
Middle Aged
Nifedipine / therapeutic use*
Propanolamines / therapeutic use*
Treatment Outcome
Vasodilator Agents / therapeutic use*
Reg. No./Substance:
0/Carbazoles; 0/Propanolamines; 0/Vasodilator Agents; 0K47UL67F2/carvedilol; 21829-25-4/Nifedipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled...
Next Document:  Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.